May 15, 2020 / 12:00 AM / 18 days ago

BRIEF-Balt Says Received Approval From FDA To Begin Trial For Chronic Sub-Dural Hematoma

May 14 (Reuters) - Balt:

* BALT RECEIVES IDE APPROVAL FROM THE FDA TO BEGIN THE STEM TRIAL

* BALT SAYS RECEIVED IDE APPROVAL FROM FDA TO BEGIN STEM FOR TREATMENT OF CHRONIC SUB-DURAL HEMATOMA Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below